JAZZ PHA reported $1.24B in Operating Expenses for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US USD 9.62B 590M
ALKERMES ALKS:US USD 325.26M 12.26M
Amarin AMRN:US USD 95.02M 62.25M
Cara Therapeutics CARA:US USD 34.57M 90K
Coherus Biosciences CHRS:US USD 96.84M 29.03M
Eli Lilly And LLY:US USD 5.47B 200.3M
Emergent Biosolutions EBS:US USD 395.8M 113.8M
Endo International Ordinary Shares ENDP:US USD 1.18B 1.13B
Halozyme Therapeutics HALO:US USD 106.99M 21.41M
Heron Therapeutics HRTX:US USD 68.44M 8.69M
Hikma Pharmaceutical HIK:LN USD 1.24B 280M
Horizon Pharma HZNP:US USD 768.1M 3.34M
IONIS PHARMACEUT IONS:US USD 359.91M 140.99M
Mckesson MCK:US USD 69.25B 216M
Merk MRK:US USD 10.32B 624M
Nektar Therapeutics NKTR:US USD 74.49M 3.43M
Pacira Pharmaceuticals PCRX:US USD 181.85M 35.67M
Perrigo Ordinary Shares PRGO:US USD 1.12B 57.6M
Pfizer PFE:US USD 19.12B 5.9B
Phibro Animal Health PAHC:US USD 228.8M 9.96M
Revance Therapeutics RVNC:US USD 194.33M 87.83M
Supernus Pharmaceuticals SUPN:US USD 132.99M 45.88M
Teva Pharmaceutical Industries TEVA:US USD 4.74B 1.56B
Xeris Pharmaceuticals Inc XERS:US USD 48.31M 191K
Zoetis ZTS:US USD 1.45B 113M